Abstract
The vast majority of microbial life is beneficial to human existence, performing functions as diverse as fixing nitrogen for agriculture, degrading toxic materials for bioremediation, and producing natural products which are difficult or impossible to synthesize chemically. In human physiology, bacteria are required for digestion, produce micronutrients in the gut, help to ward off dangerous pathogens, and may be involved in the immune response and healthy cognitive function. In fact, mitochondria, the power-producing organelle in eukaryotic cells, has an independent genome which resembles that of bacteria and is probably an endosymbiotic organelle. Many bacteria are pathogenic to humans and animals via a variety of mechanisms, including the production of toxic chemicals. Viruses, on the other hand, are not technically alive, having no metabolic machinery of their own, and are supramolecular structures which use the host cell’s genome to replicate. Both bacteria and viruses have a long history of causing human disease, either by natural outbreaks or by intentional use by humans. As biological warfare or bioterrorism agents, they have profoundly different attributes from chemical, radiological, nuclear, or kinetic weapons in that their effects are usually delayed, which makes response and attribution difficult – in some cases they are contagious and can spread rapidly through aerosol or physical contact transmission, and there are no medical treatments for many pathogens and toxins. The potential of disease caused by both the deliberate dissemination of biological pathogens and the emergence of new diseases should be viewed as a public health issue to which the tools of risk management are brought to bear. While nature produces, on average, a new major disease every year, advances in synthetic engineering biology now raise the specter of designing de novo new threats for which there are no countermeasures. The possibility of these “biotechnological” agents will require a strategic approach to counter the threat.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alvarez ML, Cardineau GA (2010) Prevention of bubonic and pneumonic plague using plant-derived vaccines. Biotechnol Adv 28(1):184–196
Arima Y, Shimada T (2015) Epidemiological situation of Ebola virus disease in West Africa. Uirusu 65(1):47–54
Balenghien T, Cardinale E et al (2013) Towards a better understanding of Rift Valley fever epidemiology in the south-west of the Indian Ocean. Vet Res 44:78. https://doi.org/10.1186/1297-9716-44-78
Benner SA (1988) Redesigning the molecules of life. Springer, Heidelberg, pp 115–175
Bush GW (2003) Homeland security presidential directive 5 management of domestic incidents. White House Office of the Press Secretary, Washington, DC
Clinton WJ (1995) Presidential decision directive 39 U.S. Policy on Counterterrorism
Clinton, WJ (1998) Presidential decision directive 62 protection against unconventional threats to the homeland and Americans overseas
Danzig RJ (2009) A policymaker’s guide to bioterrorism and what to do about it. National Defense University Press, Washington, DC
DiEuliis D, Berger K, Gronvall G (2017) Biosecurity implications for the synthesis of horsepox, an orthopoxvirus. Health Secur 15:629. https://doi.org/10.1089/hs.2017.0081
Elrazak MA (1991) Brucella optic neuritis. Arch Internal Med 151:776–778
Forrester NL et al (2017) Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas. PLoS Negl Trop Dis 11(8):e0005693
Gal Y, Mazor O et al (2017) Treatments for pulmonary ricin intoxication: current aspects and future prospects. Toxins (Basel) 9. https://doi.org/10.3390/toxins9100311
Gibbs WW (2004) Synthetic life. Sci Am 290:74–81
Gibson DG et al (2010) Creation of a bacterial cell controlled by a chemically synthesized genome. Science 329(5987):52–56
Hooshangi S, Bentley WE (2011) LsrR quorum sensing “switch” is revealed by a bottom-up approach. PLoS Comp Biol 7(9):e1002172. https://doi.org/10.1371/journal.pcbi1002172
Hornick RB, Eigelsbach HT (1966) Aerogenic immunization of man with live tularemia vaccine. Bacteriology Rev 30:532–538
Hwang D, Lee IY et al (2009) A systems approach to prion disease. Mol Sys Biol 5:252. https://doi.org/10.1038/msb200912
Inglesby TV, Dennis TV et al (2000) Plague as a biological weapon: medical and public health management. JAMA 281:1735–1745
Jacobs BL, Landland JO et al (2009) Vaccinia virus vaccines: past, present, future. Antivir Res 84(1):1–13
Kahn AS, Tshio FK et al (1999) The re-emergence of Ebola hemorrhagic fever: democratic Republic of the Congo 1995. J Infect Dis 179(1):S76–S86
Koneman EW, Allen SD et al (1997) Color atlas and textbook of diagnostic microbiology, 5th edn. Lippincott, Estados Unidos
Koo B, Jin CE et al (2017) A rapid bio-optical sensor for diagnosing Q fever in clinical specimens. J Biophotonics 11:e201700167. https://doi.org/10.1002/jbio.201700167
Laforce FM (1994) Anthrax. Clin Infect Dis 19(6):1009–1013
Lake GC, Francis E (1922) Six cases of tularemia occurring in laboratory workers. Public Health Rep 37:392–413
Linthicum KJ, Britch SC, Anyamba A (2016) Rift Valley fever: an emerging mosquito-borne disease. Annu Rev Entomol 61:395–415
Lundberg L, Carey B, Kehn-Hall K (2017) Venezuelan equine encephalitis virus capsid: the clever caper. Viruses 9(10):279. https://doi.org/10.3390/v9100279
Lushniak BD (2014) Antibiotic resistance: a public health crisis. Public Health Rep 129(4):314–316
Maksyutov RA, Yakubitskyi SN et al (2017) Comparing new-generation candidate vaccines against human orthopoxvirus infections. Acta Nat 9(2):88–93
Mandani N, Giraud P et al (2017) First draft genome sequences of three strains of Francisella tularensis subsp. holarctica isolated from hares and a tick in France. Genome Announc 5(45):e-00993-17
Mee C (1990) How a mysterious disease laid low Europe’s masses. Smithsonian 20:66–79
Mobley JA (1995) Biological warfare in the twentieth century: lessons from the past, challenges for the future. Mil Med 160:547–553
Ochman H, Raghavan R (2009) Excavating the functional landscape of bacterial cells. Science 326(5957):1200–1201. https://doi.org/10.1126/science.1183757
Ohl CA, Luther VP (2011) Antimicrobial stewardship for inpatient facilities. Journal of Hospital Medicine. 6:S4–S15.
Paternina LE, Rodas JD (2018) Sampling design and mosquito trapping for surveillance of arboviral activity. Methods Molec Biol 1604:89–100. https://doi.org/10.1007/978-1-4939-6981-4_6
Regis E (1999) The biology of doom: America’s secret germ warfare project. Holt & Co., New York ISBN 0805057641
Roest HI, Bossers A et al (2013) Clinical microbiology of Coxiella burnetii and relevant aspects for the diagnosis and control of the zoonotic disease Q fever. Vet Q 33(3):148–160
Roth TM, Foley J, Wright S (2017) Abiotic and biotic contributors to support inter-epidemic Francisella tularensis in an agricultural peri-urban environment. Vector Borne Zoonotic Dis 17(11):764–772
Srinivasan A, Krause CN, DeShazer D (2001) Glanders in a military research microbiologist. NEJM 345:256–258
Tao P, Mahalingam M et al (2017) A bivalent anthrax-plague vaccine that can protect against two Tier-1 bioterror pathogens, Bacillus anthracis and Yersinia pestis. Front Immunol 8:687. https://doi.org/10.3389/fimmu.2017.00687
Van Roeden SE, Bleeker-Rovers CP et al (2017) Treatment of chronic Q fever: clinical efficacy and toxicity of antibiotic regimens. Clin Infect Dis. https://doi.org/10.1093/cid/cix886
Von Bredow J, Myers M et al. (1999) Agroterrorism: Agricultural infrastructure vulnerability. Annals of the New York Academy of Sciences. 894:168–180
Weaver, SC and Reisen, WK (2010) Present and future arboviral threats. Antiviral Research, 85(2):328–345
Weir E (2000) Anthrax: Of bison and bioterrorism. Canadian Medical Association Journal. 163(5):607
Whitfield SJC, Griffiths GD et al. (2017) Production, characterization and testing of an ovine antitoxin against ricin; potency and mechanisms of action. Toxins. 9(10):1–19.
General References
Army Field Manual (FM 3-5) NBC Decontamination
Army Field Manual (FM 4-02.7) Health services support in an NBC environment
Army Field Manual (FM 8-284) Treatment of biological warfare casualties
U.S. Army Medical Research Institute of Infectious Diseases. Medical management of biological casualties handbook, 7th edn
Disclaimer
Approved for Public Release; Distribution Unlimited. Case Number 18–0266.
The author’s affiliation with The MITRE Corporation is provided for identification purposes only and is not intended to convey or imply MITRE’s concurrence with, or support for, the positions, opinions, or viewpoints expressed by the author.
The opinions, interpretations, conclusions, and recommendations are those of the author and are not to be interpreted as representing the official views or policies, either expressed or implied, of the Department of Defense.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Valdes, J.J., Valdes, E.R. (2022). Biological Agents: Threat and Response. In: Masys, A.J. (eds) Handbook of Security Science. Springer, Cham. https://doi.org/10.1007/978-3-319-91875-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-91875-4_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91874-7
Online ISBN: 978-3-319-91875-4
eBook Packages: Physics and AstronomyReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics